ReviewFrontiers in neurology2022
HMGB1 in nervous system diseases: A common biomarker and potential therapeutic target.
Di Mao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
39 papers cite it
this papercites it
ReviewFrontiers in neurology2022
Di Mao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.